Go back to previous page
CA046 A randomized Phase III Study of weekly ABI-007 plus Gemcitabine verus Gemcitabine alone in patients with Metastatic Adenocarcinoma of the pancreas.
D3820C00006 A randomized, double-blind study, placebo controlled study to assess the efficacy and safety of NKTR-118 in relieving opiod-induced constipation (OIC) in patients with cancer-related pain.
1200.75 LUX-Breast 1; an open label, randomized Phase III Trial of BIBW 2992 (Afatinib) and Vinorelbine versus Trastuzumab and Vinorelbine in patients with Metastatic HER2-Overexpressing breast cancer failing one prior trastuzumab treatment.
CC-5013-CLL-002A Phase 3, multi-ceter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of lenalidomide (Revlimid) as maintenance therapy for patients with B-cell chronic lymphocytic leukemia following second-line therapy (the Contunuum trial).
Connect MM: The Multiple Myeloma Disease Registry
Connect CLL: The Chronic Lymphocytic Leukmia Disease Registry
04-21 A Phase III, multi-ceter, randomized, controlled study to assess the efficacy and safety of ON 01910.Na administered to a 72-hour continuous intravenous infusion every other week in Myelodysplastic Syndrome patients with excess blasts relapsing after, or refactory to, or intolerant to Azacitidine or Decitabine.
SCI-SCV-MUC-P2b-002 A phase 2b, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of three different doses of SCV-07 in Attenuating Oral Mucositis in subjects with head and neck cancer receiving chemotherapy and radiotherapy.
CA180330 Studying interventions for managing patients with chronic myeloid leukemia in chronic phase: The 5 year prospective cohort study (Simplicity).